Carregant...

Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans

BACKGROUND: The cannabinoid (CB) system is a rational novel target for treating opioid dependence, a significant public health problem around the world. This proof-of-concept study examined the potential efficacy of a CB(1) receptor partial agonist, dronabinol, in relieving signs and symptoms of opi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Alcohol Depend
Autors principals: Lofwall, Michelle R., Babalonis, Shanna, Nuzzo, Paul A., Elayi, Samy Claude, Walsh, Sharon L.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910823/
https://ncbi.nlm.nih.gov/pubmed/27234658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2016.05.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!